Avenda Health AI & Clinical Documentation: Features, Pricing & Alternatives
AI platform mapping prostate cancer extent to guide personalized treatment decisions.
Avenda Health's Unfold AI platform precisely maps prostate cancer to support personalized treatment decisions and improve outcomes.
Our take
Avenda Health is best suited for Urology practices and health systems seeking AI-driven prostate cancer mapping for treatment planning.. FDA-cleared AI technology for prostate cancer mapping..
Main limitation: limited availability; currently only in the united states through providers.. Scored 2.1/5 across the EHRAtlas scorecard.
Avenda Health Overview
Avenda Health is a medical technology company focused on prostate cancer diagnosis and treatment through artificial intelligence. Its flagship product, Unfold AI, analyzes standard-of-care data—MRI, fusion biopsy, pathology, and PSA—to generate a 3D Cancer Estimation Map (CEM) that visualizes the location and extent of prostate cancer. This mapping is intended to help physicians plan focal therapies, surgeries, and radiation more precisely, with the goal of preserving quality of life and reducing residual cancer.
The platform is FDA-cleared and based on research with large patient datasets. Clinical studies cited by the company suggest that Unfold AI improves cancer detection and treatment outcomes compared to MRI alone. The company positions its solution as a decision-support tool for urologists, oncologists, and patients navigating prostate cancer care.
Avenda Health is currently available in the United States exclusively through healthcare providers, with ongoing efforts to expand insurance coverage and availability. The company does not sell directly to patients and pricing varies by provider. Its business model centers on partnerships with clinical practices and health systems.
Latest Avenda Health News
Avenda Health Evaluation
Scored against the same 7 dimensions used in the EHRAtlas Scorecard. 0 = not enough public information to score. These are analyst estimates, not endorsements — verify during a demo. Buyers should validate capabilities, pricing, implementation requirements, and fit during vendor evaluation.
Age, customer base, feature depth.
Product is FDA-cleared and based on 10 years of research, but limited public information on customer base and feature depth.
Solo/small, mid, enterprise, or niche.
Targets healthcare providers, likely urology practices and health systems, but no explicit segmentation provided.
What sets it apart from alternatives.
Unfold AI provides 3D cancer estimation maps that are clinically validated to identify cancer extent more accurately than MRI alone.
Systems it connects to out of the box.
No information on integrations with EHR, imaging, or other systems is provided on the website.
HIPAA, SOC 2, ONC, FDA, other.
AI algorithms are FDA-cleared, but no mention of HIPAA, SOC 2, or other certifications.
In-house vs outsourced, SLAs, channels.
No details on support model, SLAs, or channels are available.
How it charges and what the entry point is.
Pricing varies by provider and is not fully covered by insurance; no specific pricing model disclosed.
Avenda Health Pricing
| Practice Size | Monthly (per provider) | Implementation | Notes |
|---|---|---|---|
| Mid | Contact vendor | Contact vendor | Pricing varies by provider; not yet fully covered by insurance. |
Pricing is indicative. Always request a formal quote and ask about module, interface, and annual maintenance fees.
Key Features
Cancer Estimation Map (CEM)
Generates a 3D heatmap of prostate cancer location and extent from standard-of-care data.
AI-Powered Analysis
Uses proprietary AI algorithms trained on hundreds of thousands of patient data points.
Treatment Planning Support
Aids in surgical planning, focal therapy, radiation, and active surveillance decisions.
FDA-Cleared
The AI algorithms used are FDA-cleared for prostate cancer analysis.
Fit
Specialties Served
Integrations & Compliance
Capabilities
Systems It Connects To
- billing
- hie
- lab-int
Compliance
| Item | Status | Note |
|---|---|---|
| ONC Certified Health IT | No | Not listed in the ONC CHPL active database. |
| FDA cleared | Yes | AI algorithms are FDA-cleared. |
| HIPAA | Not published | Not mentioned on website. |
| SOC 2 | Not published | Not mentioned on website. |
Avenda Health Pros & Cons
Pros
- FDA-cleared AI technology for prostate cancer mapping.
- Clinically validated to improve cancer detection over MRI alone.
- May preserve quality of life by enabling focal therapy.
- Backed by 10 years of research and large patient dataset.
Cons
- Limited availability; currently only in the United States through providers.
- Not fully covered by insurance; pricing varies.
- No information on integrations with EHR or other systems.
- Support and implementation details are not publicly available.
Explore EHR Software Ecosystem: Integrations, Partners & Add-Ons Compare Avenda Health with other Oncology and Urology EHR vendors or browse the full EHR & Healthcare Technology Solutions Index.
Are you Avenda Health? Claim your vendor profile, add product details, and reach practices researching EHRs. Claim Profile/Get Listed
Spotted an error? We publish this data as-is from CMS sources. If a practice or vendor listing is wrong, email support@ehratlas.com and we'll review it.
About This Data & Methodology
Source: This profile is assembled from the vendor's public website (features, capabilities, customer stories, media, and product updates) and EHRAtlas analyst evaluation. Compliance claims, pricing, and integration details should be verified directly with the vendor before making a purchase decision.
Methodology: Where available, we extract structured facts (customers, outcomes, integrations, security certifications) directly from the vendor's own published pages. Claims are linked to their source. Scores reflect analyst judgment based on available public evidence and are not endorsements.
Updates: Vendors are re-scanned periodically. Profile last reviewed on the date shown in the hero.
Corrections: If you spot an error or a change in the vendor's product, capabilities, or pricing, email us and we'll review it.
Spotted an error or need to submit a correction? Email support@ehratlas.com.